{"id":"placebo-with-thimerosal","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions (pain, erythema, swelling)"},{"rate":null,"effect":"Systemic reactions (fever, myalgia, fatigue)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a control arm preparation used in clinical trials, typically to evaluate the safety and tolerability of thimerosal as a vaccine preservative. Thimerosal is an ethylmercury-containing compound historically used to prevent bacterial and fungal contamination in multi-dose vaccine vials. The placebo formulation allows researchers to assess whether observed effects are attributable to thimerosal itself or to other trial components.","oneSentence":"Placebo with thimerosal serves as a control formulation containing the preservative thimerosal without active pharmaceutical ingredients.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:29:11.191Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in vaccine safety and immunogenicity trials"}]},"trialDetails":[{"nctId":"NCT06223919","phase":"PHASE3","title":"Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad Nacional de Colombia","startDate":"2023-12-16","conditions":"Monkeypox","enrollment":8686},{"nctId":"NCT05289375","phase":"NA","title":"Efficacy of the Vacucis Candida® Autovaccine","status":"NOT_YET_RECRUITING","sponsor":"University of Santiago de Compostela","startDate":"2025-04-30","conditions":"Oral Candidiasis, Oral Candidiasis Recurrent, Radiotherapy; Complications","enrollment":46},{"nctId":"NCT04522830","phase":"PHASE2","title":"A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19","status":"COMPLETED","sponsor":"Beech Tree Labs, Inc.","startDate":"2020-07-30","conditions":"SARS-CoV-2 Infection","enrollment":28},{"nctId":"NCT02415842","phase":"","title":"A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-26","conditions":"Immunologic Tests","enrollment":414},{"nctId":"NCT00133549","phase":"PHASE2","title":"9-valent CRM 197 Pneumococcal","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2000-11","conditions":"Pneumococcal Infection","enrollment":180},{"nctId":"NCT00912496","phase":"PHASE1","title":"Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-06","conditions":"Influenza","enrollment":637},{"nctId":"NCT00333398","phase":"PHASE3","title":"Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-06","conditions":"Influenza","enrollment":1359}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo with Thimerosal","genericName":"Placebo with Thimerosal","companyName":"National Institute of Allergy and Infectious Diseases (NIAID)","companyId":"national-institute-of-allergy-and-infectious-diseases-niaid","modality":"Biologic","firstApprovalDate":"","aiSummary":"Placebo with thimerosal serves as a control formulation containing the preservative thimerosal without active pharmaceutical ingredients. Used for Control arm in vaccine safety and immunogenicity trials.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}